X0508 4 2026-03-04 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0002025621 Shields Matthew C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 124 DVORA HANEVI'A ST., TEL AVIV L3 6944020 ISRAEL false true false false EVP, Global Operations false Restricted Share Units 2026-03-04 4 A false 33424 0 A Ordinary Shares 33424 33424 D Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. Restricted share units were granted on March 4, 2026, with 8,356 vesting on each of March 4, 2027, March 4, 2028, March 4, 2029, and March 4, 2030. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. /s/ Dov Bergwerk as attorney-in-fact for Matthew Shields 2026-03-06